NCT04519723View on ClinicalTrials.gov

Laser 360iQ: Optimal Light-laser Combination Therapy

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Photodamage
Interventions
DEVICE

Assess the safety and efficacy of light-laser therapy using the Harmony XL and Dye-VL (500-600nm), Q-Switched 1064nm, Er:YAG 2940nm modules in combination .

Trial Locations (1)

55424

Zel Skin & Laser Specialist, Edina

All Listed Sponsors
lead

Alma Lasers Inc.

INDUSTRY

NCT04519723 - Laser 360iQ: Optimal Light-laser Combination Therapy | Biotech Hunter | Biotech Hunter